We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Sanofi stands ninth on our list and is currently making ...

As frustrating as that is, there are things you can do to make sure that your doctor turns your symptoms into an accurate diagnosis. Here's what to know. The first step to getting an accurate ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 20, ...

Nimbus has spread to at least 22 countries Symptoms include "razor blade" sore throat Once again, a new strain of COVID has hit the country, and that includes the state of Massachusetts.

Treatment and Prognosis Patients with BP will often go into remission if young, usually less than 65 years old, and in good health, but erupting blisters can continue for 10 or more years. About ...

EM does not have the chronic nature that BP has; lesions in EM minor clear in 2–3 weeks, and EM major lesions heal in 3–6 weeks with symptomatic treatment (Pruksachatkunakorn, 2007).

The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

A new COVID-19 variant named "Nimbus" has been detected in the U.S. and is spreading rapidly. Here's what to know about symptoms and vaccines.

The approval of Dupixent for bullous pemphigoid is expected to offer new hope to patients who have previously faced limited treatment options. With the potential to effectively manage symptoms and ...

TUESDAY, June 24, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid. The approval is based on ...

EMERGING immunotherapies are transforming the treatment landscape for pemphigus and bullous pemphigoid, two distinct autoimmune blistering skin diseases marked by pathogenic autoantibodies and ...